Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia.

scientific article published on 2 March 2011

Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1023730781
P356DOI10.1186/CC10072
P932PMC publication ID3219332
P698PubMed publication ID21366903
P5875ResearchGate publication ID50265911

P50authorKyong Ran PeckQ38641275
Kyung Mok SohnQ42408453
Mi Kyong JoungQ56926819
Gee Young SuhQ86988444
Soo-Youn MoonQ87057921
Doo Ryeon ChungQ88159934
Eun Jeong JooQ88300621
Hae Suk CheongQ90299494
Seung Min ChungQ91125991
P2093author name stringJae-Hoon Song
Young-Eun Ha
Jeong-a Lee
P2860cites workGuidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated PneumoniaQ22241905
A new method of classifying prognostic comorbidity in longitudinal studies: development and validationQ29547376
APACHE II: a severity of disease classification systemQ29547729
Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescriptionQ33912931
Present situation of antimicrobial resistance in KoreaQ34505590
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU settingQ34509624
High prevalence of ceftazidime-resistant Klebsiella pneumoniae and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: a KONSAR program in 2004.Q34576870
Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational studyQ34999543
Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU.Q35022253
Clinical approach to the patient with suspected ventilator-associated pneumonia.Q36171407
Impact of BAL data on the therapy and outcome of ventilator-associated pneumoniaQ36856249
Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patientsQ39487652
CDC definitions for nosocomial infections, 1988Q39605670
Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumoniaQ39608037
Impact of adequacy of initial antimicrobial therapy on the prognosis of patients with ventilator-associated pneumoniaQ39661220
A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumoniaQ39684575
Antibiotic utilization and outcomes for patients with clinically suspected ventilator-associated pneumonia and negative quantitative BAL culture resultsQ39733706
Impact of clinical guidelines in the management of severe hospital-acquired pneumonia.Q46001422
De-escalation therapy in ventilator-associated pneumoniaQ47868453
Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia.Q51206353
Nosocomial pneumonia. A multivariate analysis of risk and prognosis.Q52573110
The Value of Routine Microbial Investigation in Ventilator-Associated PneumoniaQ57238120
Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patientsQ68535966
Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study GroupQ71510515
Diagnosing pneumonia during mechanical ventilation: the clinical pulmonary infection score revisitedQ73372258
P433issue2
P921main subjectpneumoniaQ12192
intensive care unitQ5094647
P304page(s)R79
P577publication date2011-03-02
P1433published inCritical CareQ5186602
P1476titleImpact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia
P478volume15

Reverse relations

cites work (P2860)
Q38679343A Systematic Review of the Definitions, Determinants, and Clinical Outcomes of Antimicrobial De-escalation in the Intensive Care Unit
Q38712768A retrospective study of antibiotic de-escalation in patients with ventilator-associated pneumonia in Malaysia.
Q36666990A trial of discontinuation of empiric vancomycin therapy in patients with suspected methicillin-resistant Staphylococcus aureus health care-associated pneumonia
Q37563029An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy
Q55018607Antibiotics De-Escalation in the Treatment of Ventilator-Associated Pneumonia in Trauma Patients: A Retrospective Study on Propensity Score Matching Method.
Q43240867Antimicrobial de-escalation in septic cancer patients: is it safe to back down?
Q36455347Antimicrobial de-escalation of treatment for healthcare-associated pneumonia within the Veterans Healthcare Administration
Q38198157Antimicrobial stewardship of β-lactams in intensive care units
Q36774787Characteristics and outcomes of anti-infective de-escalation during health care-associated intra-abdominal infections
Q92356332Chinese guidelines for the diagnosis and treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in adults (2018 Edition)
Q90329443Confounding by indication of the safety of de-escalation in community-acquired pneumonia: A simulation study embedded in a prospective cohort
Q44692768De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock.
Q37132283Determinants of Deescalation Failure in Critically Ill Patients with Sepsis: A Prospective Cohort Study.
Q36089167Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearance
Q33749860Factors influencing the implementation of antibiotic de-escalation and impact of this strategy in critically ill patients
Q40370311Impact of combination therapy and early de-escalation on outcome of ventilator-associated pneumonia caused by Pseudomonas aeruginosa
Q49061695Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients: a retrospective observational study
Q42264706Infection control team activity and recent antibiograms in the Kobe University Hospital
Q36078359Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
Q83390539Management of antimicrobial use in the intensive care unit
Q64977019Réévaluation clinico-biologique de l’antibiothérapie probabiliste en réanimation des brules.
Q91992768Safety of antimicrobial de-escalation for culture-negative severe pneumonia
Q27002517Strategies for appropriate antibiotic use in intensive care unit
Q38433744Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.
Q38307688The bacterial pneumonias: a new treatment paradigm
Q50141533The use of best practice alerts with the development of an antimicrobial stewardship navigator to promote antibiotic de-escalation in the electronic medical record
Q38271775Ventilator-associated pneumonia: present understanding and ongoing debates
Q48185895When antibiotic treatment fails